Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Exploring Circulating Long Non-Coding RNAs in Mild Cognitive Impairment Patients’ Blood

Version 1 : Received: 8 October 2023 / Approved: 9 October 2023 / Online: 9 October 2023 (11:36:08 CEST)

A peer-reviewed article of this Preprint also exists.

De Felice, B.; Coppola, C.; Bonavita, S.; Signoriello, E.; Montanino, C.; Farinella, F. Exploring Circulating Long Non-Coding RNAs in Mild Cognitive Impairment Patients’ Blood. Biomedicines 2023, 11, 2963. De Felice, B.; Coppola, C.; Bonavita, S.; Signoriello, E.; Montanino, C.; Farinella, F. Exploring Circulating Long Non-Coding RNAs in Mild Cognitive Impairment Patients’ Blood. Biomedicines 2023, 11, 2963.

Abstract

miRNA regulatory axes in blood of MCI patients, which includes lncRNA-SNHG16, lncRNA-H19 and lncRNA-NEAT1. Microarray investigations have demonstrated modifications in the expression of long non-coding RNAs (lncRNA) in blood of patients with MCI compared with control samples. This is the first study to explore lncRNA profiles in Mild Cognitive Impairment blood. Our study proposes RNAs targets involved in molecular pathways connected to the pathogenesis of MCI.

Keywords

lncRNAs; MCI; SNHG16; H19; NEAT1; Alzheimer’s disease; mild cognitive impairment

Subject

Biology and Life Sciences, Neuroscience and Neurology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.